American Herbal Products Association (AHPA) > Education > Webinars

Upcoming Webinars

Subscribe to AHPA Updates to be notified of upcoming AHPA events.

CA Prop 65 Webinar: Update on Regulatory, Compliance and Litigation Developments

An overview of several significant developments related to Prop 65

Companies that sell products in California should understand these recent changes and be prepared for additional changes that are in development. A solid compliance plan will help your company mitigate the risk of expensive litigation.

How to Submit an NDI Notification Without Objection

Attendees receive complementary access to AHPA's NDI Database

Attend this webinar to learn how to successfully traverse the NDI notification process and avoid common pitfalls that can result in FDA objections.

FDA Inspection Trends, cGMP Compliance Issues and Responding to an FDA 483

Two-part webinar will provide insights into recent cGMP inspection trends

Two-part webinar will provide data on recent FDA inspections, an overview of emerging compliance issues and strategies for responding to an FDA 483 in order to avoid an FDA warning letter.

FDA Inspection Trends, cGMP Compliance Issues and Responding to an FDA 483

Two-part webinar will provide insights into recent cGMP inspection trends

Two-part webinar will provide data on recent FDA inspections, an overview of emerging compliance issues and strategies for responding to an FDA 483 in order to avoid an FDA warning letter.
RSS

Webinar Recordings

Legal experts provide tips for FDA inspections

Presented May 15, 2014

tips for handling every aspect of a FDA inspection, from pre-inspection preparation to interacting with on-site inspectors, and responding to observations and warning letters

FDA cGMP Inspections & Emerging Compliance Issues for Dietary Supplements

Presented: December 19 , 2012

Industry experts will provide attendees with an insider's view of where FDA focuses its efforts during dietary supplement cGMP inspections to help participants fulfilling their all-important compliance efforts.

Marketing Red Flags for Dietary Supplements

Presented: October 25, 2012

This webinar focuses on a number of regulatory compliance challenges that the dietary supplement industry encounters in its efforts to navigate regulatory compliance while creating successful product marketing campaigns.

cGMP Compliance Series Teleseminar: Variances

Presented: November 1, 2011

Variances--an exception or departure from approved protocol--occur and this webinar will help you prepare for them.

FDA's NDI Guidance: What You Need to Know

Presented: July 19, 2011

A panel of experts help attendees understand the key elements of FDA's New Dietary Ingedient (NDI) draft guidance and how it will impact businesses in the supplement industry.

Living with Proposition 65: Preventative Measures & Defending Against a 60-Day Notice

Presented: October 18, 2010

As much as 30% of the national sales of dietary supplements may be to California consumers - but companies that market in that state may encounter high penalties for non-compliance with a California law known as Proposition 65. The focus of this law for the supplement class has been on the warnings required for products that may inadvertently contain small amounts of heavy metals, such as arsenic, cadmium, and mercury, and especially lead.

Guidance for Addressing FDA cGMP Inspections of Dietary Supplement Facilities

Understand your rights and obligations when FDA conducts a cGMP inspection

This Guidance for Addressing FDA Inspections of Dietary Supplement Facilities has been prepared to assist AHPA members in understanding their rights and obligations when the U.S. Food and Drug Administration conducts an inspection of a facility in which dietary supplements or ingredients are manufactured, processed, packed or held. It provides descriptions and analyses of the current federal laws that are relevant to inspection of dietary supplement facilities and suggestions of how to prepare for and conduct inspections in a manner that fully complies with these laws.

cGMP Compliance Series: How to Conduct & Manage a FDA Inspection

Presented: July 30, 2009

This webinar covers the extent of FDA's authority during an inspection, so you know your rights.

cGMP Compliance Series: Record Keeping, Document Control & How to Write SOPs

Presented: May 28, 2009

Learn how to create, manage and control documents for good GMP practices, inspectors, auditors and safety.

CGMP Compliance Series: Setting and Meeting Specifications for Contaminants in Finished Products

Presented: January 22, 2009

Under the cGMP rule, it is the responsibility of the manufacturer to identify contaminants likely or certain to be present in or on components received and to establish limits to prevent adulteration of these components.
RSS
12345

2018 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.